Celldex Therapeutics, Inc

$33.41
+0.01 (+0.03%)

Market Capitalization:

$2.62B

Celldex Therapeutics, Price Chart

Celldex Therapeutics, Price Chart1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM33.4133.2833.1433.0132.8832.7432.61

Celldex Therapeutics, Volume Chart

Celldex Therapeutics, Volume Chart1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM5:19 AM272.03K233.17K194.31K155.45K116.59K77.72K38.86K

Celldex Therapeutics, Market Segments

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$33.41
Close$33.41
Low$33.41
Low Change0.00 (0.00%)
High$33.41
High Change+0.00 (+0.00%)
Range$0.00
Volume186.487K
Dollar Volume$6.23M

Regular Trading Hours Yesterday

+0.53(+1.61%)
Open$32.87
Close$33.40
Low$32.26
Low Change-0.61 (-1.86%)
High$33.46
High Change+0.59 (+1.79%)
Range$1.20
Volume1.76M
Dollar Volume$58.79M

Premarket Yesterday

+0.09(+0.28%)
Open$32.71
Close$32.80
Low$32.56
Low Change-0.15 (-0.46%)
High$32.80
High Change+0.09 (+0.28%)
Range$0.24
Volume711
Dollar Volume$23.32K

Celldex Therapeutics, News

There is no current news for this stock at the moment.

Celldex Therapeutics, Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Celldex Therapeutics, Moving Averages

5 Day Moving Average (SMA5)$32.64
10 Day Moving Average (SMA10)$31.20
20 Day Moving Average (SMA20)$30.78
50 Day Moving Average (SMA50)$32.01
100 Day Moving Average (SMA100)$30.07
200 Day Moving Average (SMA200)$28.02

Celldex Therapeutics, Statistics

Average Volume (30 Days)842.62K
P/E Ratio (Current)-8.98
EPS (Current)-$3.61
Dividend Yield0.00%
Free Cash Flow-$226.25M
Cash Ratio0.69
Current Ratio8.92
Quick Ratio8.92
Debt to Equity0.00
Enterprise Value$2.51B
EV to EBITDA-8.21
EV to Sales2898.12
Price to Book5.58
Price to Cash Flow
Price to Free Cash Flow
Price to Sales2939.37
Return on Assets-0.55%
Return on Equity-0.62%

Celldex Therapeutics, Stock Splits

There have been 2 stock splits for Celldex Therapeutics, (CLDX). The last reverse stock split occured on February 11, 2019 and reduced the outstanding shares at a ratio of 15:1.

DateTypeRatio
Feb 11, 2019Reverse15:1
Mar 7, 2008Reverse12:1

Celldex Therapeutics, Dividends

There have been no dividends for Celldex Therapeutics, (CLDX).